Skip to main content
. 2022 Aug 24;22(17):6355. doi: 10.3390/s22176355

Figure 3.

Figure 3

COVID-19 disease severity biomarker panel consisting of four biomarkers: cTnI (A), CK-MB (B), MYO (C), and NT-proBNP (D). Standard curves were fit to the concentration data, and specificity was demonstrated for each antigen at high concentration (inset images). Reproduced from [20] with permission from the Royal Society of Chemistry.